The intent of this clinical study is to answer the questions: 1) is the proposed treatment feasible; 2) is treatment effective in improving the disease pathology of patients with diagnosed diabetic erectile dysfunction.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
30
The subjects will receive intracavernous injection of HUCMSC.
The subjects will receive intracavernous injection of the mixture of injectable collagen scaffold and HUC-MSCs.
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Nanjing, Jiangsu, China
RECRUITINGSafety and Tolerability assessed by Adverse Events
Time frame: 1 month after intervention
Improvement in IIEF-5 (International Index of Erectile Function)
The subjects must fill in the questionnaire of IIEF-5 every visit to evaluate erectile function
Time frame: 1,3,6,9 and 12 months
Improvement in penile colour Doppler ultrasonography
Time frame: 1,3,6,9 and 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.